Our proprietary technology has been successfully applied to over 1,500 drug molecules. By designing precise crystallization conditions tailored to your target compound's physicochemical properties, we identify the most optimal solid form for development.
For new candidate compounds, our goal is to find the thermodynamically most stable crystal form quickly and efficiently.
Through structural analysis and property testing, we predict salt or co-crystal formation sites to guide targeted screening.
We deliver results with less material consumption, fewer experiments, and shorter timelines through precision-designed experiments.
Deploying polymorph, salt, and co-crystal screening strategies based on specific early-stage development needs.
When an innovative drug enters Phase II or III, comprehensive patent protection is critical for long-term success.
We identify all possible crystal forms—especially metastable forms—suitable for industrial development to secure your intellectual property.
Relying on experience across hundreds of IP projects, we utilize tiered strategies to ensure thorough coverage.
We utilize enabling crystallization methods to discover and protect forms that traditional methods might miss.
Subscribe to be the first to get the updates!
